This study is looking at how well a special type of scan, called PSMA PET, combined with an MRI (magnetic resonance imaging) can find prostate cancer. The PSMA PET scan uses a small amount of a drug called 68Ga-PSMA-11, which helps highlight prostate cancer cells. Researchers want to see if this combination is better than the usual ways doctors find prostate cancer. You might be able to join if you are a man at least 18 years old and your doctor suspects you might have prostate cancer, especially if you've had an MRI showing some concerns or have other risk factors like a high PSA (prostate-specific antigen) level. The study aims to enroll 338 participants. The main goals of the study will be measured after 12 months.

Study design

This is an open-label, single-arm study, meaning you and your doctors will know what treatments you are receiving. It plans to enroll 338 participants across multiple locations.

What's involved

You would undergo MRI and PSMA PET scans, followed by a standard prostate biopsy. If your doctor decides not to perform a biopsy, you will have a follow-up visit at 6 months.

Compensation

Not stated in the trial record.

Follow-up

The primary goals of the study are measured at 12 months. If a biopsy is not performed, you will have a follow-up visit at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.